Contraception

In this interview, Michael Krychman, MD, a community-based gynecologist in Newport Beach, California, takes a look at 2022 advances within the contraceptive space, as well as looks toward the future.

Community pharmacists need more support and resources to provide quality contraceptive counseling and care, according to a study published in BMJ Sexual and Reproductive Health.

Women on Medicaid with opioid use disorder (OUD) who use medications for opioid use disorder (MOUD) are more likely to use contraception and to undergo female sterilization than peers not prescribed MOUD, according to a study in Contraception.

Fertility myths and declining sexual satisfaction may contribute to shortfalls in contraceptive use after cancer treatment, a new study concludes.

Understanding the effects is imperative for patient satisfaction.

An umbrella review of meta-analysis studies on hormonal contraceptives published in JAMA Network Open finds no high-quality evidence that they cause major adverse health outcomes such as stroke or cancer.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, comment on unmet needs and challenges faced by patients looking for contraception.

Experts in gynecology share practical resources for patients and providers on the currently available contraceptive options.

Drs Jenna Beckham and Thomas Kimble review the benefits of newly approved contraceptive systems, such as use in women with higher BMIs and ease of access.

The contraception and abortion care workforce in the United States significantly decreased during the first year of the COVID-19 pandemic, according to a research letter published in JAMA Network Open.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, discuss patient misconceptions around contraceptive options and the impact on adherence.

Drs Jenna Beckham and Thomas Kimble comment on hormonal patch and vaginal gel contraceptives.

Experts in gynecology review other contraception methods, including the contraceptive ring and drospirenone and estetrol tablets.

The US Food and Drug Administration recently updated its guidelines for dispensing mifepristone (the “abortion pill”) to now include certified pharmacies.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, provide an overview of newly approved contraceptive modalities.

Thomas Kimble, MD, reviews potential cardiovascular risks associated with some contraceptives.

A substudy of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which compared three highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device (Cu-IUD) or the levonorgestrel (LNG) implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate (DMPA-IM).

Drs Jenna Beckham and Thomas Kimble discuss the safety and efficacy of contraceptives for patients with a higher body mass Index (BMI).

Thomas Kimble, MD, provides an overview of currently available hormonal contraceptive options.

Experts in gynecology consider the role of pharmacists and other healthcare providers in contraceptive counseling and education.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, highlight key points to share with a patient who has just been prescribed a contraceptive.

The rate of unintended pregnancies throughout the US military declined significantly since 2005, according to a study published in Contraception.

Heavy menstrual bleeding is the No. 1 risk factor for intrauterine device (IUD) expulsion, according to an analysis of a US cohort study.

Drs Jenna Beckham and Thomas Kimble share their thoughts on initiating conversations surrounding contraception options with patients.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, provide an overview of the use of contraception methods in the US.

A study published in the journal Contraception shows patients sought guidance from clinics to remove their own IUDs at a much higher rate than before the pandemic.

Results from a randomized controlled trial study suggest dextromethorphan may even worsen patient pain experience.

An over-the-counter (OTC) progestin only pill (POP) could potentially reduce the overall number of unintended pregnancies in the United States, according to a modeling study published in the journal Contraception.

The major conclusion of a demographic and health survey of sexually active women from the sub-Saharan African country Chad is that education is key for adopting modern contraceptive methods.

Rhesus (Rh) immunoglobulin should be given only after 12 weeks gestation for spontaneous abortion, or for medication or uterine aspiration abortion, according to a new consensus statement from the Society of Family Planning (SFP).